Meet the NVLX team: Kenneth L. Waggoner has almost four decades of experience in management, business, operations and law. Professionally, Dr. Ryan has become a pioneer in the field of emerging biotechnology, specializing in assisting small companies with insight and bringing products to market through the rigorous FDA approval process. Dr. Crabtree served as Interim CEO of PhytoCeutica, Inc., where he assisted in preparation and review of FDA documents, clinical study protocols, investment acquisitions, and contracts and business plans.Ms. Patricia Gruden has made a substantial impact in many companies over the years. It was in 1995 that she became cofounder of the company that has since become Nuvilex. Read More here: http://www.nuvilex.com/management
(0)
(0)
PharmaCyte Biotech Inc. (PMCB) Stock Research Links